Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.500
0.00 (0.00%)
Apr 24, 2025, 5:24 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 58.40 million as of April 25, 2025. Its market cap has increased by 34.50% in one year.
Market Cap
58.40M
Enterprise Value
30.05M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.50
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 58.40M, an increase of 264.11%. That is a compound annual growth rate of 7.08%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 59.80B |
| Danel (Adir Yeoshua) | 2.40B |
| Kamada | 1.38B |
| Bait Bakfar | 967.88M |
| Novolog (Pharm-Up 1966) | 812.75M |
| Ilex Medical | 709.55M |
| BrainsWay | 607.59M |
| SofWave Medical | 549.59M |